baber/WOPTO huggingface dataset:
Patent NZ-334191-A (NZ)
Title: Method for improved selectivity in photo-activation and detection of molecular diagnostic agents
Inventor: WACHTER ERIC A
IPC: A61B17/00
Filed: 1997-10-27
Abstract: isclosed is a method for the imaging of a particular volume of plant or animal tissue, wherein the plant or animal tissue contains at least one photo-active molecular agent.  The method comprises the steps of treating the particular volume of the plant or animal tissue with light sufficient to promote a simultaneous two-photon excitation of the photo-active molecular agent contained in the particular volume of the plant or animal tissue, photo-activating at least one of the photo-active molecular agents in the particular volume of the plant or animal tissue, thereby producing at least one photo-activated molecular agent, wherein the at least one photo-activated molecular agent emits energy, detecting the energy emitted by the at least one photo-activated molecular agent, and producing a detected energy signal which is characteristic of the particular volume of plant or animal tissue. The application also provides a method for the imaging of a particular volume of material, wherein the material contains at least one photo-active molecular agent.
Patent NZ-334993-A (NZ)
Title: Rubber teat cup element reinforced area near head
Inventor: MAIER JAKOB
IPC: A01J5/08
Filed: 1997-08-21
Abstract: A rubber teat cup element includes a reinforced area 18 of greater stiffness between the teat insertion aperture 49, and retaining flange 8. There is also an area 19 just below the stiffened region 18 that is elastically deformable relative to the stiffened region. The stiffened region 18 and deformable region 19 define a chamber 23. This construction is said to provide a better fit to an animal's teat 15.
Patent NZ-336027-A (NZ)
Title: Pharmaceutical compositions for freeze drying comprising a nucleotide analogue, mannitol and a modifying additive which is sodium chloride or a polyol
Inventor: BLAND CHRIS
IPC: A61K9/14
Filed: 1997-12-11
Abstract: A pharmaceutical composition comprising a nucleotide analogue, mannitol and a modifying additive which is sodium chloride or a polyol which is suitable for freeze drying.
Patent NZ-337932-A (NZ)
Title: Flux guiding and cooling apparatus for induction heating units
Inventor: ESKILDSEN CHRISTIAN
IPC: H05B6/36
Filed: 1998-03-13
Abstract: The core of an induction heating cooker element is constructed of a plurality of radially disposed core segments 1, the pole pieces 2 on the outside of the segments forming a core rim 3 and the pole pieces 4 on the inside of the segments forming a central pole 5.  A cylindrical coil 6 is wound onto each core segment.
Patent NZ-502565-A (NZ)
Title: Use of phanquinone for the treatment of Alzheimers's disease optionally with vitamin B12 and clioquinol
Inventor: GEROLYMATOS PANAYOTIS NIKOLAS
IPC: A61K31/47
Filed: 1998-07-17
Abstract: Phanquinone (4,7-phenanthroline-5,6-dione) is used to treat or prevent Alzheimer's disease.
Patent NZ-503813-A (NZ)
Title: Method and apparatus for recording of encrypted digital data on a portable token
Inventor: MAILLARD MICHEL
IPC: H04N7/16
Filed: 1998-09-22
Abstract: A  method for transmission and recording of  scrambled digital   data  in  which  scrambled  data  is   transmitted together with a control word for descrambling the data,  the control word (Ce) itself being encrypted by a first key  and transmitted  in encrypted form, the scrambled  digital  data and  encrypted  control  word being received  by  a  decoder (2020)  possessing an equivalent of the first key  necessary to  decrypt  the encrypted control word, the  decoder  being further  adapted  to  pass the digital  data  in  its  still scrambled  form  to  a digital recording device  (4005)  and characterised  in that the decrypted control word  (Ce)  for descrambling  the scrambled data is thereafter  re-encrypted by  means of a second key (C2) stored in a portable  support device  (4004) adapted to be received by the decoder  (2020) and/or  digital  recording device (4005),  the  re-encrypted control  word  being  recorded together with  the  scrambled data  on the digital recording medium (4006). When replaying the  recording, the control word is decrypted  by  means  of the  second  key stored on the support means and  thereafter used to descramble the recording.
Patent NZ-508275-A (NZ)
Title: A membrane or matrix containing siloxane based elastomer for controlling the permeation rate of drugs
Inventor: JUKARAINEN HARRI
IPC: C08J5/18
Filed: 1999-06-11
Abstract: A membrane or matrix for controlling the permeation rate of a drug comprises a siloxane based elastomer composition comprising at least one elastomer and optionally a non-crosslinked polymer.  The elastomer composition comprises poly(alkylene oxide) groups, present in one or more forms of alkoxy-terminated grafts of polysiloxane units, blocks or a mixture of alkoxy terminated grafts and blocks where these are linked to the polysiloxane units by silicon-carbon bonds.
Patent NZ-509840-A (NZ)
Title: Cholesterol ester transfer protein inhibitors and their use in pharmaceutical to alter plasma lipid levels by increasing HDL and lowering LDL levels
Inventor: DENINNO MICHAEL PAUL
IPC: C07D409/12
Filed: 1999-09-10
Abstract: Cholesteryl ester transfer protein inhibitors of the Formula (I) wherein: R1 is Y, W-X or W-Y W is a carbonyl, thiodarbonyl, sulfinyl or sulfnyl X is O-Y, -S-Y, -N(H)-Y or -N-(Y)2. Y is Z or an optionally substituted 1 to 10 membered straight or branched carbon chain where one or two carbon atoms, other than the connecting carbon can be replaced with O, N (or N oxide) or S (or S oxide). Z is 3 to 8 membered carbocyclic or heterocyclic ring or a bicyclic ring system. R2 is an optionally substituted 1 to 6 membered straight or branched carbon chain where one or two carbon atoms other than the connecting carbon can be replaced with O, N (or N oxide) or S (or S oxide) or an optionally substituted carbocyclic or heterocyclic ring which ring ma be optionally be attached via an (C1-C4)alkyl group. Provided that R2 is not methyl. R3 is hydrogen or Q. Q is an optionally substituted 1 to 6 membered straight or branched carbon chain where one carbon atom other than the connecting carbon can be replaced by O, N (or N oxide) or S (or S oxide).  In particular Q may be substituted by V. V is a 3 to 8 membered carbocyclic or heterocyclic ring or a bicyclic ring system. R4 is Q1 or V1. Q1 is an optionally substituted 1 to 6 membered straight or branched carbon chain where one carbon atom other than the connecting carbon can be replaced by O, N (or N oxide) or S (or S oxide). V1 is a carbocyclic or heterocyclic ring. Wherein R3 must contain V or R4 must contain V1. R5, R6 , R7 and R8  are each independently hydrogen, a bond, nitro or halo wherein said bond is substituted with T or a 1 to 12 membered straight or branched carbon chain where one or two carbon atoms, other than the connecting carbon can be replaced with O, N (or N oxide) or S (or S oxide). R5 and R6 , or R6 and R7 and/or R7 and R8  may also be taken together and can form at least one optionally substituted 4 to 8 membered ring that is partially saturated or fully unsaturated optionally having 1 to 3 heteroatoms independently selected from nitrogen, sulfur and oxygen. Provided that R1 is not (C1-C6)alkyl. Pharmaceutical compositions containing such inhibitors can be used to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and in diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis, cardiovascular diseases, dyslipidemia and vascular complications of diabetes, obesity or endotoxemia in some mammals, including humans.
Patent NZ-511216-A (NZ)
Title: Drug delivery device having a membrane composed of a siloxane based elastomer having 3,3,3-trifluoropropyl groups for the delivery of progestins and estrogens
Inventor: RUOHONEN JARKKO
IPC: A61K9/00
Filed: 1999-10-26
Abstract: An implantable drug delivery device for the controlled release of a therapeutically active agent, especially a progestin or an estrogen, over a prolonged period of time, comprises a core containing the therapeutically active agent, and a membrane made of an elastomer encasing the core.  The elastomer is a siloxane-based elastomer that includes 3,3,3-trifluoropropyl groups attached to the Si-atoms of the siloxane units.
Patent NZ-513329-A (NZ)
Title: Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid
Inventor: ROE CHARLES R
IPC: A23L1/30
Filed: 2000-02-03
Abstract: Use of a composition comprising a seven carbon fatty acid compound for treatment of a fatty acid metabolic defect, preventing hypoglycaemia, used to fuel heart tissue, recuperation from cardiac or other high risk surgery, stimulating growth rate of a prematurely born infant and providing a source of rapid energy. The seven carbon fatty acid compound may be selected from 4- methylhexanoate, 4-methylhexenoate, 3-hydroxy-4- methylhexanoate, 5-methylhexanoate, 5-methylhexenoate and 3- hydroxy-5-methylhexanoate.
Patent NZ-515885-A (NZ)
Title: Optically pure (S.S) reboxetine in the treatment of conditions in which inhibiting reuptake of norepinephrine (nor adrenaline) provides relief
Inventor: WONG ERIK H F
IPC: A61P25/28
Filed: 2000-06-22
Abstract: Compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. The compositions comprise a compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of at least about 5000. Examples of such compounds include reboxetine, and more preferably the optically pure (S,S) enantiomer of reboxetine. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat or prevent a human from suffering, a physiological or psychiatric disease, disorder, or condition.
Patent NZ-519316-A (NZ)
Title: Method of making a fecral material and such material
Inventor: BERGLUND ROGER
IPC: C22C38/00
Filed: 2000-12-18
Abstract: A method of producing an FeCrAl material by gas atomisation, wherein in addition to containing iron (Fe), chromium (Cr) and aluminium (Al) the material also contains minor fractions of one or more of the materials molybdenum (Mo), hafnium (Hf), zirconium (Zr), yttrium (Y), nitrogen (N), carbon (C) and oxygen (O). The invention is characterised by causing the smelt to be atomised to contain 0.05-0.50 percent by weight tantalum (Ta) and, at the same time, less than 0.10 percent by weight titanium (Ti). According to one highly preferred embodiment, nitrogen gas (N2) is used as an atomising gas to which a given amount of oxygen gas (O2) is added, said amount of oxygen gas being such as to cause the atomised powder to contain 0.02-0.10 percent by weight oxygen (0) at the same time as the nitrogen content of the powder is 0.01-0.06 percent by weight. The invention also relates to a high temperature material.
Patent NZ-519502-A (NZ)
Title: Floor waste assembly
Inventor: REED SELWYN
IPC: E03F5/04
Filed: 2002-06-12
Abstract: A floor waste assembly (10) for receiving and discharging waste water. The assembly comprises: an inlet (7) which receives waste water discharged from a floor or a waste water producing appliance, a major portion of the inlet being disposed in a floor space defined by an upper floor surface and a lower floor surface and a minor part of the inlet extending below the lower floor surface; an outlet which discharges the waste water from the assembly; a conduit (6) intermediate the inlet and the outlet and engaging via a first end the minor part of the inlet and via a second end, the outlet; wherein at least a part of the outlet is disposed within a floor space (5) above the lower surface of the floor such that an upper surface of a water barrier formed in the assembly between the inlet and the outlet is disposed within a region defined by the upper and lower floor surfaces.
Patent NZ-522562-A (NZ)
Title: A variable resistance user interface including a textile-form flexible conducive electrodes and a textile-form variably resistive element
Inventor: LUSSEY DAVID
IPC: H01H13/00
Filed: 2001-05-17
Abstract: A variable resistance user-interface comprises textile-form flexible conductive electrodes (10, 12) connective to associated circuitry (16), and a textile-form variably resistive element (14) capable of exhibiting a change in electrical resistance on mechanical deformation formed as coating applied to a textile sandwiched between the electrodes, wherein at least one electrode is supported on non-conducting textile as conductive yarn woven, knitted or embroidered into the non-conductive textile.
Patent NZ-523452-A (NZ)
Title: 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
Inventor: HOFFMANN TORSTEN
IPC: A61P25/24
Filed: 2001-07-20
Abstract: Compounds of general formulas IA or IB; where: R1 is (a), (b), (c), (d) or is -NH(CH2)2OH, -NR3C(O)CH3 or -NR3C(O)-cyclopropyl; R2 is methyl or chloro; R3 is hydrogen or methyl; R is -(CH2)2OH; and n is 1 or 2 These compounds have an affinity for the NK-1 receptor and may be useful in treating or preventing conditions where such a pharmacological action is useful. A process for the producing compounds of formula IA or IB is disclosed.
Patent NZ-531354-A (NZ)
Title: Reusable, spring driven autoinjector with shape memory alloy drive spring
Inventor: GILBERT SCOTT
IPC: A61M5/20
Filed: 2003-06-24
Abstract: The present invention provides a reusable spring device autoinjector. The drive mechanism of the autoinjector of the present invention includes one or more drive springs formed of a shape memory alloy. Therefore, by alternating the shape memory alloy forming the one or more drive springs between austenite phase before an injection and a martensite phase after injection, the reusable autoinjector of the present invention is capable of providing an injection force that is higher than the compressive force required to cock the drive mechanism in preparation for a subsequent injection operation.
Patent NZ-531395-A (NZ)
Title: Process for manufacturing a decorative object using fossilised natural resin or tree sap
Inventor: RIELLY SEAN MATTHEW
Filed: 2004-02-25
Abstract: A process for manufacturing ornaments from fossilised natural resin or sap is disclosed. The process includes the steps of preparing a workpiece of fossilised resin of a desired size and grade and placing this within a mould 3. A hardening agent is added into the mould cavity 2 and the mould is then heated to a temperature between 23 and 50 degrees Celcius for a period of time to harden the resin into the desired shape. This process is suitable for materials such as Kauri gum that are too fragile and soft in their natural state to withstand sawing and grinding processes involved in manufacturing decorative objects.
Patent NZ-534687-A (NZ)
Title: Human monoclonal antibodies to prostate specific membrane antigen (PSMA) seq id 54
Inventor: DEO YASHWANT M
IPC: A61P35/00
Filed: 2003-01-28
Abstract: Isolated human monoclonal antibodies which bind to PSMA, and related antibody based compositions and molecules, are disclosed. The human antibodies can be produced in a nonhuman transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, nonhuman transgenic animals and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
Patent NZ-536937-A (NZ)
Title: Player information delivery - independent feature
Inventor: BENNETT NICHOLAS LUKE
IPC: A63F13/10
Filed: 1999-11-26
Abstract: A gaming system comprises a plurality of gaming consoles each of which have display means and game control means arranged to control images displayed on the display means. The game control is arranged to display a base game wherein one or more random events are caused to be displayed and if a predefined winning event or combination of events result, a prize is awarded. The system is characterised in that an animated character is periodically displayed on the console to communicate information to the player using the console. The character is independent of the current base game and common for a plurality of different base games which may be played on the consoles. (62) Divided out of 528036
Patent NZ-539684-A (NZ)
Title: Humidity activated delivery systems for cyclopropenes encapsulated in a molecular encapsulation agent complex
Inventor: JACOBSON RICHARD MARTIN
IPC: A01N27/00
Filed: 2005-04-28
Abstract: Disclosed herein is a composition comprising: (a) a molecular encapsulation agent, selected from substituted and unsubstituted cyclodextrins, crown ethers, and zeolites, and mixtures thereof, within which is encapsulated one or more cyclopropenes of the formula shown; where R is H or a substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, phenyl, or naphthyl group; wherein the substituents, when present, are independently halogen, alkoxy, or substituted or unsubstituted phenoxy; and (b) one or more hygroscopic or deliquescent materials selected from one or more polyethers, one or more polyols, and mixtures thereof. Also disclosed is an article of manufacture comprising the composition described above enclosed in a water impermeable container; a method to release a cyclopropene from the composition described above, comprising the step of contacting the composition with water; and a method to deliver a cyclopropene compound to a plant to inhibit an ethylene response in the plant, comprising the step of contacting the composition described above with water in the presence of a plant.
Patent NZ-541634-A (NZ)
Title: Improved antitumoral treatments
Inventor: BERTINO JOSEPH R
IPC: A61K38/15
Filed: 2004-03-12
Abstract: Disclosed is the use of aplidine or an aplidine analogue in the manufacture of a medicament for the treatment of primary and/or metastatic cancer by combination therapy employing aplidine or an aplidine analogue with another drug selected from the group consisting of methotrexate, cytosine arabinoside, mitoxantrone, vinblastine, methylprednisolone and doxorubicin.
Patent NZ-542938-A (NZ)
Title: Methods for converting a target polynucleotide into readable information chains for subsequent determination of the sequence of the target polynucleotide
Inventor: LEXOW PREBEN
IPC: C12Q1/6874
Filed: 2004-04-16
Abstract: Disclosed is a method to identify specific characteristics of a target polynucleotide in a sample, and comprises the steps of: i) attaching to one end of each target polynucleotide in the sample a polynucleotide signal sequence that is specific for the characteristic under study; ii) contacting the target polynucleotides with a molecule that interacts with the target polynucleotide if the characteristic is present; iii) attaching a polynucleotide adapter sequence to those targets polynucleotides that interact with the molecule of step (ii), the adapter being attached at the end of the target polynucleotide opposite that at which the signal sequence is attached; iv) carrying out a polynucleotide amplification reaction on those target polynucleotides that comprise both the adapter and signal sequence, optionally repeating steps (i) to (iv) for other characteristics; and (v) identifying which signal sequences are present on the amplified products, and in which order, to thereby determine the characteristics of each target polynucleotide.
Patent NZ-545739-A (NZ)
Title: Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
Inventor: REBIERE FRANCOIS
IPC: C07C317/44
Filed: 2004-09-17
Abstract: Disclosed is a method for preparing a sulphoxide compound of formula (I) either as a single enantiomer or in an enantiomerically enriched form wherein the substituents are disclosed in the specification comprising the steps of contacting a pro-chiral sulphide of formula (II) wherein the substituents are disclosed in the specification with a metal chiral ligand complex, selected from a titanium, zirconium, manganese or vanadium chiral ligand complex, an organic base and an oxidising agent in an organic solvent; and optionally isolating the obtained sulphoxide of formula (I).
Patent NZ-546268-A (NZ)
Title: Automatic clothes dryer
Inventor: CAROW JAMES P
Filed: 2006-03-29
Abstract: Automatic clothes dryer comprises a cabinet defining an interior space in which is rotatably mounted a drum that defines a drying chamber, a heater assembly having a heating element for heating air, and a motor for rotating the drum. A blower is mounted within the interior space and is fluidly coupled to the drying chamber for moving heated air through the drying chamber. A first temperature sensor is mounted upstream of the heating element. A second temperature sensor is mounted downstream of the blower. Outputs from the temperature sensors are utilized with one or more methods to determine the air flow characteristics through the dryer.
Patent NZ-550324-A (NZ)
Title: Monoclonal antibodies to hepatocyte growth factor
Inventor: KIM KYUNG JIN
IPC: C07K16/30
Filed: 2004-08-13
Abstract: Provided is a chimeric or humanized monoclonal antibody (mAb) that binds and neutralizes human Hepatocyte Growth Factor (HGF) as a single agent wherein the antibody competes with an antibody produced by a hybridoma deposited as ATCC Number PTA5162 for binding to HGF. Further provided is the use of the antibody in the manufacture of a medicament for cancer.
Patent NZ-553744-A (NZ)
Title: System for and method of audio signal processing for presentation in a high-noise environment
Inventor: BONGIOVI ANTHONY
Filed: 2005-08-01
Abstract: A system for processing an audio signal comprises: a primary equalizer that produces an equalized audio signal by adjusting the amplitude of the low frequency portions of the audio signal corresponding to audible bass sounds and adjusting in the opposite direction the amplitude of the high frequency portions of the audio signal corresponding to audible treble sounds; a compressor that produces a compressed audio signal by compressing the dynamic range of the audio signal; and a mirror equalizer that produces a substantially opposite effect as the primary equalizer. The adjusting and the adjusting in the opposite direction intersect between a crossover range of frequencies produces a substantially negligible gain in the crossover range. The audio signal is used as both a source and control for the compressor, and the compressor compresses the audio signal by attenuating the high amplitude portions of the audio signal and amplifying the low amplitude portions of the audio signal.
Patent NZ-555339-A (NZ)
Title: Device and method for detection of analytes
Inventor: BOONE JAMES H
IPC: C12M1/36
Filed: 2005-11-23
Abstract: The present disclosure provides assays and devices for detection of substances in liquid samples. The assays and devices utilize passive diffusion between a porous material and a porous membrane containing a specific binding pair member to enable detection of the substance of interest.
Patent NZ-555495-A (NZ)
Title: Fungicidal mixtures containing prothioconazole and metrafenone
Inventor: AMMERMANN EBERHARD
IPC: B60Q1/50
Filed: 2003-03-19
Abstract: Disclosed is 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazole-3-thione (prothioconazole) of formula I or a salt or adduct thereof and at least one further fungicidal compound consisting of metrafenone of formula (IV).